38 experts join forces to improve lung health for youth: the #LungHealth4Life Community of Practice kicks off
On 25 February 2025, EFA hosted the first online meeting of the LungHealth4Life Community of Practice (CoP). The event marked the beginning of a collaborative...
European Commission prioritises competitiveness, as prevention retreats – EFA perspective on the 2025 Work Programme
On 11 February, the European Commission presented its annual Work Programme for 2025, setting the legislative agenda for the year ahead. This is the first...
EFA Community illustrates why EU Member States should implement the new Air Quality Directive
For most people, breathing is effortless. Yet for millions of Europeans with allergy, asthma, chronic obstructive pulmonary disease (COPD) and severe allergy,...
Why indoor air quality must be a European priority
We spend 90% of our time indoors, yet indoor air quality (IAQ) remains overlooked in EU policymaking. For millions of people with allergy and respiratory...
Shaping the future of COPD care in Europe: a call for urgent action at the European Parliament
The European Federation of Allergy and Airways Diseases Patients' Associations (EFA) recently brought together at the European Parliament patient advocates,...
EFA welcomes EMA plan to draft guidelines on nasal spray treatments
EFA responded to the European Medicines Agency's (EMA) consultation on a concept note to develop new guidelines aimed at ensuring therapeutic equivalence...
A new era for patient access to care in Europe: the EU HTA Regulation enters into force
On January 12, 2025, the Health Technology Assessment Regulation (HTAR) officially came into force, marking a significant milestone in European healthcare,...
Protecting students with food allergies: EFA and GA2LEN publish joint action plan on anaphylaxis management in schools
For children and youth with food allergies, the classroom is not just a place for learning, but also a space where careful precautions are essential to...
The EU expands the list of critical medicines: what is in it for allergy, atopic eczema, asthma and COPD care?
On the 16th of December, the European Medicines Agency (EMA) published the updated version of the critical medicines list (CML), marking a significant...
Is the EU better prepared for a pandemic? EFA’s evaluation of the EU serious cross-border threats to health regulation
While COVID-19 was hitting hard the world in Mach 2020, the European Union started reviewing its legal tools and financial instruments to address health...
10 life-saving steps to manage anaphylaxis: a joint manifesto by EFA and GA2LEN ANACare
Food allergy can profoundly impact daily life, turning ordinary moments into potential crises. For some, a simple meal or snack can lead to a life-threatening...
EFA shares asthma patients’ perspective on EAACI Guidelines for indoor air quality
Indoor air can be a silent threat to those living with asthma, filled with pollutants that trigger or worsen their condition.
In November, we worked with...
Shaping the future of food safety: EFA attends the European Food Safety Authority Stakeholder Forum
On 27 November, EFA participated in the seventh Stakeholder Forum meeting of the European Food Safety Authority (EFSA) in Brussels. This year, the meeting...
EFA responds to EMA guideline consultations on inhalation and nasal medicines for allergy, asthma and COPD
Inhalation and nasal medicinal products are crucial in the treatment and management of allergy, asthma and chronic obstructive pulmonary disease (COPD)...
EFA response to EMA’s public consultation on handling competing interests of patient experts
EFA has responded to the European Medicine Agency’s (EMA) public consultation on the draft policy on handling of competing interests of scientific committee...
EFA attends European Commission Health Policy Platform annual meeting
On 26 November, EFA participated in the EU Health Policy Platform (HPP) annual stakeholder meeting, at the European Commission’s Directorate-General...
EFA calls for strong patient involvement in HTA consultation on medical devices
EFA has responded to a consultation on the EU Health Technology Assessment Regulation (HTAR) draft implementing regulation that determines the process...
EFA leaves a decisive footprint at Codex Alimentarius Commission meeting on food allergen labelling
Consumer trust in food labels is not a matter of convenience – it’s a matter of health safety for people living with food allergy and their families....
EFA brings the voice of food allergy patients to the confectionary industry meeting: CAOBISCO Annual Congress
For millions living with food allergy, treats like chocolate, biscuits and confectionery often come with hidden risks. Ingredients such as milk, nuts,...
EFA supports ED05-based reference doses for precautionary food allergen labelling (PAL)
Imagine standing in a grocery store, reading label after label, unsure whether the food in your hand is safe to eat. For millions of people living with...